Profiles

Keywords
Last Name
Institution

Erik Schadde

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
34
2020
61
12.170
Why?
Portal Vein
27
2020
46
10.260
Why?
Liver Neoplasms
24
2020
124
8.130
Why?
Liver
18
2020
213
6.880
Why?
Liver Regeneration
16
2020
27
6.130
Why?
Colorectal Neoplasms
11
2019
114
3.300
Why?
Ligation
21
2020
37
2.950
Why?
Embolization, Therapeutic
5
2020
80
1.900
Why?
Hepatic Stellate Cells
2
2020
10
1.670
Why?
Liver Diseases
2
2018
39
1.450
Why?
Cause of Death
3
2017
73
1.360
Why?
Registries
9
2019
195
1.310
Why?
Laparoscopy
5
2019
186
1.250
Why?
Liver Failure
4
2019
13
1.220
Why?
Postoperative Complications
11
2019
1059
1.190
Why?
Hypertrophy
4
2017
20
0.980
Why?
Organ Size
9
2019
121
0.960
Why?
Carcinoma, Hepatocellular
2
2019
44
0.910
Why?
Humans
46
2021
29841
0.860
Why?
Vascular Endothelial Growth Factor A
1
2020
75
0.860
Why?
Neovascularization, Pathologic
1
2020
70
0.850
Why?
Organ Sparing Treatments
1
2019
12
0.810
Why?
Kidney Transplantation
5
2021
143
0.810
Why?
Hepatomegaly
1
2018
6
0.800
Why?
Reperfusion Injury
1
2018
9
0.800
Why?
Neuroendocrine Tumors
5
2019
44
0.800
Why?
Male
35
2019
17153
0.800
Why?
Treatment Outcome
18
2020
3788
0.780
Why?
Publication Bias
1
2018
8
0.780
Why?
Bibliometrics
1
2018
19
0.770
Why?
Antioxidants
1
2018
68
0.760
Why?
Reactive Oxygen Species
1
2018
124
0.750
Why?
Oxidative Stress
1
2018
132
0.740
Why?
Neovascularization, Physiologic
1
2017
29
0.730
Why?
Middle Aged
26
2019
11053
0.700
Why?
Therapies, Investigational
1
2016
4
0.670
Why?
Female
30
2019
17657
0.660
Why?
Retrospective Studies
14
2021
3303
0.610
Why?
Aged
20
2019
9833
0.610
Why?
Catheter Ablation
1
2015
74
0.580
Why?
Graft Rejection
4
2008
85
0.580
Why?
Liver Transplantation
3
2015
107
0.540
Why?
Blood Loss, Surgical
3
2019
71
0.530
Why?
Animals
7
2020
5125
0.500
Why?
Risk Factors
10
2019
2549
0.490
Why?
Time Factors
9
2019
1894
0.480
Why?
Feasibility Studies
4
2016
273
0.480
Why?
Hepatic Veins
3
2020
9
0.480
Why?
Length of Stay
4
2019
360
0.450
Why?
Operative Time
4
2019
94
0.450
Why?
Survival Rate
6
2018
464
0.440
Why?
Models, Animal
3
2020
149
0.420
Why?
Random Allocation
3
2018
162
0.410
Why?
Follow-Up Studies
7
2018
2017
0.410
Why?
Isoantibodies
2
2006
11
0.410
Why?
Neoplasm Staging
5
2018
503
0.410
Why?
Intestinal Neoplasms
2
2018
13
0.400
Why?
Pancreatic Neoplasms
3
2019
172
0.390
Why?
Antibodies, Neoplasm
1
2008
18
0.390
Why?
Stomach Neoplasms
2
2018
40
0.380
Why?
Death
1
2008
38
0.380
Why?
Swine
2
2018
109
0.380
Why?
Tissue Donors
1
2008
71
0.360
Why?
Rats, Wistar
2
2017
68
0.350
Why?
Vascular Surgical Procedures
2
2019
55
0.350
Why?
Patient Selection
4
2018
249
0.350
Why?
Immunosuppressive Agents
1
2008
167
0.340
Why?
Antibodies, Monoclonal
1
2008
309
0.340
Why?
Antibody Formation
1
2006
32
0.330
Why?
Plasmapheresis
1
2006
17
0.330
Why?
HLA Antigens
1
2006
20
0.330
Why?
Adult
15
2019
9591
0.330
Why?
Rats
2
2020
941
0.320
Why?
Prognosis
7
2019
1025
0.320
Why?
Risk Assessment
5
2019
794
0.310
Why?
Philosophy, Medical
1
2004
3
0.300
Why?
Spirituality
1
2004
54
0.280
Why?
Tissue and Organ Procurement
3
2012
36
0.260
Why?
Multivariate Analysis
4
2019
390
0.250
Why?
Cell Proliferation
2
2020
232
0.240
Why?
Databases, Factual
3
2019
357
0.240
Why?
Biliary Tract Neoplasms
1
2020
11
0.230
Why?
Severity of Illness Index
2
2019
1220
0.220
Why?
Adrenalectomy
1
2019
6
0.220
Why?
Brazil
2
2016
22
0.220
Why?
Adrenal Cortex Neoplasms
1
2019
13
0.210
Why?
Adrenocortical Carcinoma
1
2019
12
0.210
Why?
Disease Susceptibility
1
2020
82
0.210
Why?
Chemotherapy, Adjuvant
1
2019
110
0.210
Why?
Ultrasonography
2
2018
198
0.210
Why?
Conversion to Open Surgery
1
2019
4
0.210
Why?
Abdominal Neoplasms
1
2019
13
0.200
Why?
Liver Function Tests
4
2017
32
0.200
Why?
Gallium Radioisotopes
1
2018
3
0.200
Why?
Preoperative Period
1
2019
72
0.200
Why?
bcl-2-Associated X Protein
1
2018
14
0.200
Why?
Culture Media, Conditioned
1
2018
33
0.200
Why?
Paracrine Communication
1
2018
8
0.200
Why?
Cytoprotection
1
2018
12
0.200
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
33
0.200
Why?
Hepatocytes
1
2018
12
0.200
Why?
Organometallic Compounds
1
2018
24
0.200
Why?
Hospital Mortality
3
2015
178
0.200
Why?
Translational Medical Research
1
2018
24
0.200
Why?
Anesthesia
1
2018
27
0.200
Why?
Digestive System Surgical Procedures
1
2018
27
0.200
Why?
Venous Thrombosis
1
2019
47
0.190
Why?
Pulmonary Embolism
1
2019
55
0.190
Why?
Venous Thromboembolism
1
2019
53
0.190
Why?
Gastric Bypass
1
2018
55
0.190
Why?
Portal Pressure
1
2017
5
0.190
Why?
Liver Circulation
1
2017
6
0.190
Why?
Cell Line, Tumor
1
2018
288
0.180
Why?
Logistic Models
3
2016
478
0.180
Why?
Survival Analysis
2
2017
390
0.180
Why?
Hyperplasia
1
2017
25
0.180
Why?
Models, Biological
1
2020
422
0.180
Why?
Fatty Liver
1
2017
40
0.180
Why?
Melanoma
1
2017
69
0.170
Why?
Tomography, X-Ray Computed
3
2017
869
0.170
Why?
Apoptosis
1
2018
290
0.170
Why?
Cell Hypoxia
1
2016
15
0.170
Why?
Randomized Controlled Trials as Topic
1
2018
357
0.170
Why?
Antineoplastic Agents
1
2019
314
0.170
Why?
Cholangiocarcinoma
1
2016
8
0.170
Why?
Bile Duct Neoplasms
1
2016
10
0.170
Why?
Reproducibility of Results
1
2019
857
0.170
Why?
Carcinoma, Squamous Cell
1
2017
193
0.160
Why?
Primary Graft Dysfunction
1
2015
3
0.160
Why?
Adenocarcinoma
1
2017
233
0.160
Why?
Methyl Ethers
1
2015
8
0.160
Why?
Anesthetics, Intravenous
1
2015
13
0.160
Why?
Anesthetics, Inhalation
1
2015
12
0.160
Why?
Propofol
1
2015
16
0.160
Why?
Transplantation Conditioning
1
2015
36
0.160
Why?
Obesity
1
2018
316
0.150
Why?
Signal Transduction
1
2018
563
0.150
Why?
Surgeons
1
2016
70
0.150
Why?
Cohort Studies
3
2017
1911
0.150
Why?
Safety
1
2014
57
0.150
Why?
Disease Models, Animal
1
2018
813
0.150
Why?
Neoplasm Invasiveness
1
2014
104
0.140
Why?
Viscera
1
2013
2
0.140
Why?
Vascular Patency
1
2013
26
0.140
Why?
Renal Artery
1
2013
10
0.140
Why?
Aneurysm
1
2013
15
0.140
Why?
Blood Vessel Prosthesis
1
2013
27
0.130
Why?
Blood Vessel Prosthesis Implantation
1
2013
45
0.130
Why?
Pancreas Transplantation
1
2012
9
0.130
Why?
Blood Transfusion
1
2012
68
0.130
Why?
Endovascular Procedures
1
2013
78
0.130
Why?
Bilirubin
2
2016
14
0.130
Why?
Resource Allocation
1
2011
5
0.120
Why?
Health Care Rationing
1
2011
7
0.120
Why?
Linear Models
1
2012
277
0.120
Why?
End Stage Liver Disease
1
2011
17
0.120
Why?
Stents
1
2013
157
0.120
Why?
Histocompatibility Testing
1
2009
6
0.110
Why?
Liver Cirrhosis
2
2012
61
0.110
Why?
HLA-C Antigens
1
2009
9
0.110
Why?
Antilymphocyte Serum
1
2008
8
0.100
Why?
Receptors, Interleukin-2
1
2008
18
0.100
Why?
Minor Histocompatibility Antigens
1
2007
3
0.100
Why?
Disease-Free Survival
2
2019
245
0.100
Why?
Blood Vessels
1
2007
19
0.090
Why?
Immunocompromised Host
1
2008
51
0.090
Why?
Glomerular Filtration Rate
1
2008
75
0.090
Why?
Graft Survival
1
2008
111
0.090
Why?
Kidney Failure, Chronic
1
2009
168
0.090
Why?
Switzerland
2
2018
8
0.090
Why?
Heart Transplantation
1
2007
52
0.090
Why?
Antibodies, Monoclonal, Humanized
1
2008
131
0.090
Why?
Cytomegalovirus Infections
1
2008
84
0.090
Why?
Incidence
2
2021
813
0.090
Why?
HLA-DP Antigens
1
2006
1
0.080
Why?
CD8-Positive T-Lymphocytes
1
2007
176
0.080
Why?
Complement C4b
1
2006
3
0.080
Why?
Body Mass Index
2
2018
435
0.080
Why?
Peptide Fragments
1
2006
119
0.080
Why?
Aged, 80 and over
4
2017
5016
0.080
Why?
Religion and Medicine
1
2004
24
0.070
Why?
Hospitals, University
2
2018
45
0.070
Why?
Transplant Recipients
1
2021
18
0.060
Why?
Pancreas
1
2021
36
0.060
Why?
Cold Ischemia
2
2011
3
0.060
Why?
Mitotane
1
2019
3
0.050
Why?
Kidney
1
2021
205
0.050
Why?
Argentina
1
2019
1
0.050
Why?
Preoperative Care
1
2020
149
0.050
Why?
Blood Coagulation Disorders
1
2019
16
0.050
Why?
Digestive System Neoplasms
1
2018
6
0.050
Why?
Postoperative Nausea and Vomiting
1
2018
17
0.050
Why?
Serum Albumin
1
2019
28
0.050
Why?
Thymus Neoplasms
1
2018
14
0.050
Why?
Cytoreduction Surgical Procedures
1
2018
7
0.050
Why?
Europe
1
2019
83
0.050
Why?
Combined Modality Therapy
1
2019
467
0.050
Why?
Neoplasm Metastasis
1
2018
146
0.050
Why?
United States
2
2018
2402
0.050
Why?
Radionuclide Imaging
1
2017
57
0.050
Why?
Gastrointestinal Neoplasms
1
2017
25
0.050
Why?
Salvage Therapy
1
2017
39
0.050
Why?
Postoperative Period
1
2019
291
0.040
Why?
Anticoagulants
1
2019
146
0.040
Why?
Edema
1
2017
39
0.040
Why?
Treatment Failure
1
2017
186
0.040
Why?
Biopsy, Needle
1
2017
119
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
408
0.040
Why?
Ovarian Neoplasms
1
2017
79
0.040
Why?
Italy
1
2016
17
0.040
Why?
Medical Audit
1
2016
8
0.040
Why?
Hospitals, High-Volume
1
2016
10
0.040
Why?
Rabbits
1
2017
325
0.040
Why?
Neoplasm Recurrence, Local
1
2017
210
0.040
Why?
Health Care Surveys
1
2016
76
0.040
Why?
Belgium
1
2015
3
0.040
Why?
Immunohistochemistry
1
2017
497
0.040
Why?
Aspartate Aminotransferases
1
2015
19
0.040
Why?
Age Factors
1
2018
912
0.040
Why?
Sarcoma
1
2017
110
0.040
Why?
Healthcare Disparities
1
2016
75
0.040
Why?
Proportional Hazards Models
1
2016
379
0.040
Why?
Odds Ratio
1
2015
328
0.040
Why?
Predictive Value of Tests
1
2016
617
0.040
Why?
Graft Occlusion, Vascular
1
2013
24
0.030
Why?
Prospective Studies
1
2018
1809
0.030
Why?
Breast Neoplasms
1
2017
427
0.030
Why?
Case-Control Studies
1
2015
684
0.030
Why?
Lung Neoplasms
1
2018
744
0.030
Why?
Waiting Lists
1
2011
19
0.030
Why?
Health Status Indicators
1
2012
82
0.030
Why?
Guidelines as Topic
1
2011
78
0.030
Why?
Magnetic Resonance Imaging
1
2017
1220
0.030
Why?
False Negative Reactions
1
2009
16
0.030
Why?
Immunization
1
2009
49
0.030
Why?
Algorithms
1
2012
414
0.030
Why?
Receptors, CXCR3
1
2007
2
0.020
Why?
Histocompatibility
1
2007
5
0.020
Why?
Mice, Mutant Strains
1
2007
29
0.020
Why?
Child
1
2012
1505
0.020
Why?
Transplantation, Homologous
1
2007
283
0.020
Why?
Wisconsin
1
2006
6
0.020
Why?
Kidney Tubules
1
2006
13
0.020
Why?
Atrophy
1
2006
99
0.020
Why?
Kidney Glomerulus
1
2006
85
0.020
Why?
Mice
1
2007
1805
0.020
Why?
Schadde's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description